News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Aakash Desai Shared A Study Published In JTO on Datopotamab Deruxtecan In Patients With EGFR-mutated NSCLC
Aakash Desai/LinkedIn
Jun 17, 2025, 06:18

Aakash Desai Shared A Study Published In JTO on Datopotamab Deruxtecan In Patients With EGFR-mutated NSCLC

Aakash Desai, Assistant Professor and Associate Director of Phase 1 and Precision Oncology Program at the UAB O’Neal Comprehensive Cancer Center, posted on X:

“A pooled analysis of datopotamab deruxtecan in patients with EGFR-mutated NSCLC – Journal of Thoracic Oncology.
Interesting analysis ahead of the U.S. FDA.
PDUFA date: July 12, 2025
Will we see another option in EGFRm NSCLC?” 

Datopotamab

Title: A pooled analysis of datopotamab deruxtecan in patients with EGFR-mutated NSCLC

Journal: Journal of Thoracic Oncology

Authors: Myung-Ju Ahn, Aaron Lisberg, Yasushi Goto, Jacob Sands, Min Hee Hong, Luis Paz-Ares, Elvire Pons-Tostivint, Maurice Pérol, Enriqueta Felip, Shunichi Sugawara, Hidetoshi Hayashi, Byoung Chul Cho, George Blumenschein Jr., Elaine Shum, Jong-Seok Lee, Rebecca S. Heist, Robin Cornelissen, Wen-Cheng Chang, Dariusz Kowalski, Hong Zebger-Gong, Michael Chargualaf, Wen Gu, Lan Lan, Paul Howarth, Richard Joseph, Isamu Okamoto

Read the full article.

Datopotamab

More posts featuring Aakash Desai on OncoDaily.

Aakash Desai Aaron Lisberg Byoung Chul Cho cancer Dariusz Kowalski datopotamab deruxtecan EGFR-mutated NSCLC Elaine Shum Elvire Pons-Tostivint Enriqueta Felip FDA George Blumenschein Jr Hidetoshi Hayashi Hong Zebger-Gong Isamu Okamoto Jacob Sands Jong-Seok Lee Journal of Thoracic Oncology Lan Lan Luis Paz-Ares Maurice Pérol Michael Chargualaf Min Hee Hong Myung-Ju Ahn OncoDaily Oncology Paul Howarth PDUFA date Rebecca S. Heist Richard Joseph Robin Cornelissen Shunichi Sugawara U.S. FDA UAB O'Neal Comprehensive Cancer Center Wen Gu Wen-Cheng Chang Yasushi Goto
Special Coverage
Oncolibrary
Jul 7, 2025, 16:44
Botensilimab and Balstilimab Achieves 21-Month Survival in mCRC and FDA Endorsement for Global Phase 3 Trial
Blog
Jul 7, 2025, 16:07
IV Research Day Dedicated to Clinical Research Will Be Held on October 6 - European Institute of Oncology
Oncolibrary
Jul 7, 2025, 15:48
Why Colonoscopy Is the Gold Standard in Early Detection of Colon Cancer Screening
Science
Jul 7, 2025, 15:44
Giuseppe Minniti: Happy to Introduce a New Proof of Concept - Strategic Radiotherapy
Oncolibrary
Jul 7, 2025, 15:12
MASCC 2025 Highlights: Long-Term Outcomes from RCT of Mepitel Film in Breast Cancer Radiotherapy
Blog
Jul 7, 2025, 15:05
Meet Josee, an Incredible Participant in the Training of Trainers Workshop on Palliative Care - ACREOL Global
Oncolibrary
Jul 7, 2025, 14:52
Botensilimab and Balstilimab Show Durable Survival in MSS Colorectal Cancer: ESMO GI 2025 Update
Science
Jul 7, 2025, 14:51
Reirradiation Techniques, Survival Outcomes, Dose, and Toxicity in Gynecological Cancers by Dina Najjari et al.
Blog
Jul 7, 2025, 14:51
First Annual Sam-a-palooza Raised $8,000 Through Donations and Registrations - Cholangiocarcinoma Foundation
Science
Jul 7, 2025, 14:34
Fabio Girardi: The Omission of Anthracyclines for the Adjuvant Treatment of Women with TNBC
Blog
Jul 7, 2025, 14:21
Enduring Partnerships among Cancer Survivors, Advocates, and Scientists with the AACR Scientist-Survivor Program
Science
Jul 7, 2025, 14:13
Hung Trinh: First In-Depth Comparative Biomonitoring of CAR-T in Multiple Myeloma Patients